Toggle navigation
Home
Feed
Channels
Profile
Home
Feed
Channels
Profile
Medspoke's Talks
Medspoke
Medspoke
JAMA Oncology
Published October 1, 2026
Immune Checkpoint Inhibitor-Based Downstaging Therapy for Hepatocellular Carcinoma.
October 2, 2026
Medspoke
Medspoke
Gut
Published October 1, 2026
00:00
--:--
Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in col...
October 2, 2026
Share
Clinical impact of prospective circulating tumour DNA testing for minimal residual disease in colorectal cancer: the INTERCEPT programme experience.
https://www.medspoke.co/channel_journal?id=785&tap_id=14890
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
Medspoke
Medspoke
Leukemia & Lymphoma
Published October 1, 2026
Venetoclax consolidation deepens response and enables measurable residual disease-guided finite t...
October 2, 2026
Why are you reporting this TALK?
